Navigation Links
Analysis finds wide variation in lung cancer rates globally
Date:5/16/2014

ATLANTA May 16, 2014The only recent comprehensive analysis of lung cancer rates for women around the world finds lung cancer rates are dropping in young women in many regions of the globe, pointing to the success of tobacco control efforts. However, rates continue to increase among older women in many countries, indicating a need for more concentrated efforts to initiate or expand comprehensive tobacco control programs across the globe to curtail future tobacco-related lung cancer deaths. The study is published early online in Cancer Epidemiology, Biomarkers & Prevention.

Lung cancer is now the second leading cause of cancer death in women worldwide. An estimated 491,200 women died of lung cancer in 2012, more than half (57%) of whom resided in economically developing countries. Differences in smoking patterns account for much of the variation in lung cancer rates around the globe. Smoking in females became common in North America, Northern Europe, Australia, and New Zealand as early as the 1940s, but remained rare throughout the 20th century in the developing world and in places with strong social norms against it, such as the Middle East. Only recently is female smoking becoming more common in many of these countries, because of increasing social acceptance, newly open markets, and/or targeted marketing by the tobacco industry.

Because the tobacco epidemic among women has varied globally, researchers led by Lindsey Torre, MSPH documented and compared contemporary trends in lung cancer mortality, to identify opportunities for intervention. They used the World Health Organization's Cancer Mortality Database covering populations on 10 six continents to calculate age-standardized lung cancer death rates during 2006 to 2010 and annual percent change in rates for available years from 1985 to 2011 and for the most recent five years for which data is available by population and age group (3049 and 5074 years).

Lung cancer mortality rates among young women (30-49 years) were stable or declining in 47 of the 52 populations examined. In contrast, among older women (50-74 years), rates were increasing for more than half (36/64) of populations examined, including most countries in Southern, Eastern, and Western Europe and South America. Lung cancer mortality rates (per 100,000) during 2006-2010 ranged from 0.7 in Costa Rica to 14.8 in Hungary among young women and from 8.8 in Georgia to 120.0 in Scotland among older women. For both age groups, rates were highest in parts of Europe (Scotland, Hungary, Denmark) and North America and lowest in Africa, Asia, and Latin America.

"The widespread reduction in lung cancer we found in young women in many parts of the globe is encouraging, and probably reflects both successful tobacco control efforts and increased awareness about the health hazards of smoking," said Torre. "The greatest opportunity we have right now for slowing a tobacco-fueled epidemic is in those countries where smoking among women is rare, such as Africa and most of Asia. And while decreasing lung cancer death rates are encouraging, many countries have yet to implement the kinds of comprehensive tobacco control measures that have led to drops in other countries."


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Listening to bipolar disorder: Smartphone app detects mood swings via voice analysis
2. Breath analysis offers non-invasive method to detect early lung cancer
3. Large-scale identification and analysis of suppressive drug interactions
4. Efficient analysis of small quantity of cells improves chances to understand disease
5. Deep, integrated genomic analysis re-classifies lower-grade brain tumors
6. Analysis finds less research attention given to diseases of the poor
7. Mild hypothermia for treatment of diffuse axonal injury: A quantitative DTI analysis
8. Analysis supports use of risk equations to guide statin therapy
9. Analysis: 32 years of US filicide arrests
10. Whole genome analysis, stat
11. Analysis of calls to IBD clinic predicts emergency visits and hospitalizations, Pitt finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: